 40 PM / Updated 22 minutes ago BRIEF-Soligenix - Driving Towards Key Inflection Points With Two Pivotal Phase 3 Clinical Trials Reuters Staff 1 Min Read 
Jan 25 (Reuters) - Soligenix Inc: 
* SOLIGENIX - DRIVING TOWARDS KEY INFLECTION POINTS WITH TWO PIVOTAL PHASE 3 CLINICAL TRIALS Source text for Eikon: Further company coverage: